UL

inVentiv Health strengthens clinical leadership team

Monday, December 10, 2012 02:12 PM

inVentiv Health, a global provider of clinical, commercial and consulting services, has appointed Raymond Hill as executive vice president of clinical. Hill will be responsible for leading the company's clinical business segment, which includes early stage, phase II-IV and strategic resourcing.

More... »

Medpace acquires European medical device CRO MediTech Strategic Consultants

Tuesday, November 27, 2012 11:50 AM

Cincinnati-based Medpace, a privately held CRO, has acquired MediTech Strategic Consultants, a European CRO dedicated to medical device clinical trials and services related to development and commercialization of medical devices.

More... »

EastBridge Investment Group to merge with Cellular Biomedicine Group

Wednesday, November 14, 2012 09:55 AM

EastBridge Investment Group has entered into an agreement to merge with Cellular Biomedicine Group (CBMG), a translational medicine company with serial preclinical and clinical research projects, as well as multiple planned clinical trials in the Greater China market. The combined company will be headquartered in Palo Alto, Calif.

More... »

Orwin joins Array BioPharma’s board of directors

Friday, November 9, 2012 02:29 PM

Array BioPharma, a biopharmaceutical company focused on targeted small molecule drugs for the treatment of cancer, has appointed John A. Orwin, CEO of Affymax, to Array's board of directors as part of its continued evolution toward late-stage development and commercialization.

More... »

Boston Scientific to acquire Vessix Vascular

Friday, November 9, 2012 12:28 PM

Boston Scientific, a medical device company based in Natick, Mass., is extending its reach into the strategically critical renal denervation market by signing a definitive agreement to acquire Vessix Vascular, a Laguna Hills, Calif.-based held company developing novel RF balloon catheter and bipolar RF generator technology. 

More... »

PFF calls for letters of intent for 2013 Young Investigator and Established Investigator awards

Wednesday, October 24, 2012 10:11 AM

The Pulmonary Fibrosis Foundation (PFF) is accepting letters of intent for its 2013 PFF Research Fund grants.  Letters of intent will be accepted until Monday, November 26.  

More... »

SIRO Clinpharm named Indian CRO of the Year 2012

Monday, October 1, 2012 09:20 AM

SIRO Clinpharm, a drug development solutions provider, has been awarded the 'Indian CRO of the Year 2012' by Frost & Sullivan, a global growth partnership and consulting firm.

More... »

Vascular Pharma completes $16M equity financing, signs agreement with Janssen

Thursday, September 13, 2012 08:00 AM

Vascular Pharmaceuticals, a drug discovery company developing a product to treat patients with complications arising from diabetes, has successfully completed a $16 million Series A equity financing.

More... »

Pulmatrix appoints Robert Clarke as CEO

Thursday, September 6, 2012 08:28 AM

Pulmatrix, a Lexington, Mass.-based clinical stage biotechnology company, has promoted Robert Clarke, Ph.D., to the position of CEO and to the board of directors.

More... »

Allergan, Molecular Partners form two exclusive alliances in eye disease

Tuesday, August 21, 2012 10:24 AM

Allergan, a multi-specialty health care company based in Medford, Mass., and Molecular Partners, a privately-owned Swiss biotech focused on a class of biological drugs known as DARPins, have significantly expanded their existing relationship by entering into two separate agreements to discover, develop and commercialize proprietary therapeutic DARPin products for the treatment of serious ophthalmic diseases.

More... »